CorMedix closes $85M public offering of common stock, net proceeds $82.2M

CorMedix Inc.

Closed public offering of 6,604,507 shares at gross proceeds ~$85M.
Net proceeds ~$82.2M; could reach ~$94.8M if underwriters' option exercised in full.
Underwriters have a 30-day option to purchase up to 990,676 additional shares.
Proceeds to be used for general corporate purposes, including R&D and strategic transactions.
RBC Capital Markets acted as sole bookrunner; Truist, Citizens, Needham as advisors.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.